New Board Members At Outsourced Pharma

Outsourced Pharma has added representatives from Biogen, Roche-Genentech, (Sanofi) Genzyme, and Sunovion Pharmaceuticals to its Editorial Advisory Board (EAB).

Industry-leading website OutsourcedPharma.com provides information, best practices, and in-depth analysis of global outsourcing and related topics in the biotechnology and pharmaceutical industries.

Outsourced Pharma Conferences are two-day events bringing executives and leaders of biotechnology/pharmaceutical companies together with their counterparts at global service providers, to openly discuss opportunities and challenges within the industry.

The new Outsourced Pharma EAB members are:

• Thomas Holmes, Senior Director for Global External Manufacturing, Biogen
• Todd Mabe, Head of External Quality, Biologics Drug Substance, Roche-Genentech
• Piet Houwen, Head of Biologics - External Manufacturing, (Sanofi) Genzyme
• Vin Kosewski, VP Supply Chain Operations, Sunovion Pharmaceuticals, Inc.

The entire Outsourced Pharma EAB for can be found here.

The Outsourced Pharma Mission

Contract research, development and manufacturing organizations continue to increase in importance to the biotechnology and pharmaceutical industries … as well as the lives of patients around the world. The Outsourced Pharma franchise provides both sides – sponsors and service providers – the opportunity to communicate and network, and ultimately improve productivity, profitability, and the outcomes of drug programs. 

OutsourcedPharma.com readers receive a deeper exploration of the best practices and relationships between service providers and their Bio and Pharma sponsors, focusing on the development, manufacturing, and external supply chains throughout a drug’s life cycle.

Examples of editorials at OutsourcedPharma.com from the new EAB members:

• Sanofi-Genzyme Together On CMO Reputation Management
• Genentech Speaks The Language Of CMOs
• Biogen’s Outsourcing Trifold For Joint Value Creation

All of the new EAB members have also been panelists at Outsourced Pharma Conferences. Here are some of their comments:

“I look forward to Outsourced Pharma conferences, because I’m curious to hear from both CMOs and other sponsors in our industry. We have to stay focused on results, partnerships, and moving projects forward. That’s one of the continuous challenges this conference helps with.”

---  Piet Houwen

“I’m excited about these conferences in particular. There’s a good amount of senior executives I can interact with, and I can benchmark where other companies are going. I’ll learn about their challenges, and how they’re planning to bridge any roadblocks. Are there any changes in the outsourcing arena? Are there risks associated with the changes? It really helps you to understand what the roadmap is for outsourcing, and some of the risks that you can proactively mitigate moving forward.”

---  Todd Mabe

“There are two things particularly I look forward to at Outsourced Pharma conferences. One is to see how our peer companies are thinking about the same things that I need to think about, and sharing all those thoughts. Then something that I always think is under appreciated – real opportunities to network. Just striking up a conversation with a peer company can lead to something tangible and important outcomes.”

---  Thomas Holmes

Paraphrased from the guidebook to the recent Outsourced Pharma Boston conference:

“Today, long hallways of shiny booths are more artifacts of a past era than symbols of commerce. Those conferences aren’t a part of today’s leadership activities. The good news: Outsourced Pharma conferences are forming more intimate and impactful leadership communities for sponsors and suppliers. It’s where authentic discussion between panelists is equaled by the energetic participation of attendees. At this venue, pharma and biotechs engage directly in dialogue with contract research, development and manufacturing organizations. This is what leads to business opportunities on both sides.”

To receive the OutsourcedPharma.com weekly newsletter, sign up here.

For any questions, comments or follow up, feel free to contact:
Louis.Garguilo@LifeScienceConnect.com

A video of the opening remarks at Outsourced Pharma Boston 2016